Collectively, these developments provide a framework for moving flavonoid engineering beyond empirical gene manipulation towards predictive optimization of metabolic fluxes
Weight loss is not just about the number on the scale
Among patients with a prior history of CUD, semaglutide was associated with a lower, but not statistically significant, risk of recurrent CUD and the strength of the association attenuated over time (Fig
(The drug is approved by the Food and Drug Administration for weight loss under the name Wegovy.) After research demonstrated that people could lose up to 11 percent of their body weight from Ozempic, it skyrocketed in popularity as an off-label medication for weight loss
Find out which ingredient combinations to avoid in our answer to the question: Which compounds in sunscreen should I be concerned about
For context, Medicaid spending on GLP-1 drugs in Pennsylvania was $1.3bn in 2025 - a whopping twice as much as the previous year